For Immediate Release (ver versión en español abajo) Contact: Luis Scaccabarrozzi Lscaccabarozzi@latinoaids.org; Aaron Chandler AaronC@blackaids.org; Lance Toma lance@sfcommunityhealth.org National Rapid Assessment Report on Institutional impact of COVID-19 among People of Color Community-Based Providers New York, NY, February 22, 2020 - We are proud to release the Final Report of the National Rapid Assessment on the Institutional Impact of COVID-19 on Organizations Providing

Johnson & Johnson is expected to deliver preliminary late-stage trial results for its one-dose Covid vaccine candidate by the end of January.  If its jab is proven to be safe and effective, the company aims to deliver at least 1 billion doses by the end of the year.  https://www.cnbc.com/2021/01/11/johnson-johnson-covid-vaccine-analysts-are-cautiously-optimistic.html

By MATTHEW HERPER @matthewherper NOVEMBER 9, 2020 Pfizer and partner BioNTech said Monday that their vaccine against Covid-19 was strongly effective, exceeding expectations with results that are likely to be met with cautious excitement — and relief — in the face of the global pandemic. The vaccine is the first to be tested in the United States to generate

By Giorlando Ramirez, Krutika Amin, and Cynthia Cox Twitter COVID-19 deaths in the United States have surpassed 200,000, and the coronavirus is now the third leading cause of death in this country, after heart disease and cancer. Before the pandemic, the U.S. already had the highest overall mortality rate among similarly large and wealthy countries,

The Black AIDS Institute, San Francisco Community Health Center and Latino Commission on AIDS, three organizations led by and serving people of color, are joining forces to address the challenges posed by the Novel Coronavirus (COVID-19) as they utilize their existing strengths and resources to continue addressing health inequities among their constituents, including those created